1. Targeting Histones and Proteasomes: New Strategies for the Treatment of Lymphoma
   Owen A. O'Connor, 2005, Journal of Clinical Oncology CrossRef
2. Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
   Owen A. O'Connor et al, 2005, Journal of Clinical Oncology CrossRef
3. Primary gastric mucosa associated lymphoid tissue lymphoma: Clinical data predicted treatment outcome
   Milena Todorovic et al, 2008, World Journal of Gastroenterology CrossRef
4. Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts Helicobacter pylori–Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas
   Sung-Hsin Kuo et al, 2004, Journal of Clinical Oncology CrossRef
5. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-κB-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
   Liza Ho et al, 2005, Blood CrossRef